EdgarLookup

FITLIFE BRANDS, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that FITLIFE BRANDS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
29.1%
Profit Margin
Net income ÷ revenue
5.9%
Return on Assets
Net income ÷ assets
1.44x
Debt-to-Equity
Total liabilities ÷ equity
+11.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $21.74M Mar 26, 2021
FY2020 Dec 31, 2019 $19.50M Mar 26, 2021
FY2019 Dec 31, 2018 $17.08M Mar 30, 2020
FY2018 Dec 31, 2017 $17.80M Mar 22, 2019
FY2017 Dec 31, 2016 $25.31M Apr 17, 2018
FY2016 Dec 31, 2015 $17.93M Apr 17, 2017
FY2015 Dec 31, 2014 $19.96M Apr 14, 2016
FY2014 Dec 31, 2013 $19.68M Mar 31, 2015
FY2013 Dec 31, 2012 $18.09M Mar 28, 2014
FY2012 Dec 31, 2011 $12.09M Apr 1, 2013

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $17.80M Apr 17, 2018
FY2017 Dec 31, 2016 $25.31M Apr 17, 2018
FY2016 Dec 31, 2015 $17.93M Apr 17, 2017
FY2015 Dec 31, 2014 $19.96M Apr 14, 2016
FY2014 Dec 31, 2013 $19.68M Mar 31, 2015
FY2013 Dec 31, 2012 $18.09M Mar 28, 2014

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $31.45M Mar 31, 2026
FY2025 Dec 31, 2024 $28.08M Mar 31, 2026
FY2024 Dec 31, 2023 $21.43M Mar 27, 2025
FY2023 Dec 31, 2022 $12.03M Mar 29, 2024
FY2022 Dec 31, 2021 $12.50M Mar 24, 2023
FY2021 Jun 30, 2021 $3.68M Oct 13, 2022
FY2021 Mar 31, 2021 $2.80M Oct 13, 2022
FY2021 Dec 31, 2020 $9.54M Oct 13, 2022
FY2020 Sep 30, 2020 $2.60M Oct 13, 2022
FY2020 Jun 30, 2020 $1.44M Oct 13, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.33M Mar 31, 2026
FY2025 Dec 31, 2024 $8.98M Mar 31, 2026
FY2024 Dec 31, 2023 $5.30M Mar 27, 2025
FY2023 Dec 31, 2022 $4.43M Mar 29, 2024
FY2022 Dec 31, 2021 $5.41M Mar 24, 2023
FY2021 Jun 30, 2021 $1.63M Oct 13, 2022
FY2021 Mar 31, 2021 $1.41M Oct 13, 2022
FY2021 Dec 31, 2020 $8.83M Oct 13, 2022
FY2020 Sep 30, 2020 $1.38M Oct 13, 2022
FY2020 Jun 30, 2020 $25.0K Oct 13, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.06M Mar 31, 2026
FY2025 Dec 31, 2024 $13.12M Mar 31, 2026
FY2024 Dec 31, 2023 $7.55M Mar 27, 2025
FY2023 Dec 31, 2022 $5.70M Mar 29, 2024
FY2022 Dec 31, 2021 $6.23M Mar 24, 2023
FY2021 Jun 30, 2021 $2.03M Oct 13, 2022
FY2021 Mar 31, 2021 $1.26M Oct 13, 2022
FY2021 Dec 31, 2020 $4.35M Oct 13, 2022
FY2020 Sep 30, 2020 $1.40M Oct 13, 2022
FY2020 Jun 30, 2020 ($10.0K) Oct 13, 2022

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.04M Mar 31, 2026
FY2025 Dec 31, 2024 $9.97M Mar 31, 2026
FY2024 Dec 31, 2023 $7.89M Mar 27, 2025
FY2023 Dec 31, 2022 $6.01M Mar 29, 2024
FY2022 Dec 31, 2021 $6.22M Mar 24, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.44M Mar 31, 2026
FY2025 Dec 31, 2024 $9.61M Mar 31, 2026
FY2024 Dec 31, 2023 $4.22M Mar 27, 2025
FY2023 Dec 31, 2022 $4.13M Mar 29, 2024
FY2022 Dec 31, 2021 $4.48M Mar 24, 2023
FY2021 Jun 30, 2021 $3.01M Oct 13, 2022
FY2021 Mar 31, 2021 $289.0K Oct 13, 2022
FY2021 Dec 31, 2020 $5.72M Oct 13, 2022
FY2020 Sep 30, 2020 $3.48M Oct 13, 2022
FY2020 Jun 30, 2020 $1.60M Oct 13, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $42.0K Mar 31, 2026
FY2025 Dec 31, 2024 $10.0K Mar 31, 2026
FY2024 Dec 31, 2023 $106.0K Mar 27, 2025
FY2023 Dec 31, 2022 $0 Mar 29, 2024
FY2014 Dec 31, 2014 ($3.4K) Mar 31, 2015
FY2011 Dec 31, 2011 $2.1K Apr 13, 2012
FY2011 Dec 31, 2010 $14.4K Apr 13, 2012

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $106.32M Mar 31, 2026
FY2025 Dec 31, 2024 $58.53M Mar 31, 2026
FY2024 Dec 31, 2023 $55.35M Mar 27, 2025
FY2023 Dec 31, 2022 $25.71M Mar 29, 2024
FY2022 Dec 31, 2021 $21.51M Mar 24, 2023
FY2021 Jun 30, 2021 $19.49M Oct 13, 2022
FY2021 Mar 31, 2021 $17.93M Oct 13, 2022
FY2021 Dec 31, 2020 $16.62M Oct 13, 2022
FY2020 Sep 30, 2020 $9.33M Oct 13, 2022
FY2020 Jun 30, 2020 $7.72M Oct 13, 2022

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $62.68M Mar 31, 2026
FY2025 Dec 31, 2024 $22.41M Mar 31, 2026
FY2024 Dec 31, 2023 $28.31M Mar 27, 2025
FY2023 Dec 31, 2022 $4.32M Mar 29, 2024
FY2022 Dec 31, 2021 $4.16M Mar 24, 2023
FY2021 Jun 30, 2021 $4.73M Oct 13, 2022
FY2021 Mar 31, 2021 $4.52M Oct 13, 2022
FY2021 Dec 31, 2020 $4.75M Oct 13, 2022
FY2020 Sep 30, 2020 $3.28M Oct 13, 2022
FY2020 Jun 30, 2020 $3.07M Oct 13, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $43.64M Mar 31, 2026
FY2025 Dec 31, 2024 $36.13M Mar 31, 2026
FY2025 Dec 31, 2023 $27.04M Mar 31, 2026
FY2024 Dec 31, 2022 $21.39M Mar 27, 2025
FY2023 Dec 31, 2021 $17.35M Mar 29, 2024
FY2021 Jun 30, 2021 $14.76M Oct 13, 2022
FY2021 Mar 31, 2021 $13.41M Oct 13, 2022
FY2021 Dec 31, 2020 $11.87M Oct 13, 2022
FY2020 Sep 30, 2020 $6.05M Oct 13, 2022
FY2020 Jun 30, 2020 $4.65M Oct 13, 2022

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $19.39M Mar 31, 2026
FY2025 Dec 31, 2024 $13.02M Mar 31, 2026
FY2024 Dec 31, 2023 $13.29M Mar 27, 2025
FY2023 Dec 31, 2022 $358.0K Mar 29, 2024
FY2022 Dec 31, 2021 $358.0K Mar 24, 2023
FY2021 Jun 30, 2021 $358.0K Oct 13, 2022
FY2022 Apr 7, 2021 $133.0K Mar 24, 2023
FY2021 Mar 31, 2021 $225.0K Oct 13, 2022
FY2021 Dec 31, 2020 $225.0K Oct 13, 2022
FY2020 Sep 30, 2020 $225.0K Oct 13, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.89M Mar 31, 2026
FY2025 Dec 31, 2024 $5.57M Mar 31, 2026
FY2024 Dec 31, 2023 ($3.42M) Mar 27, 2025
FY2023 Dec 31, 2022 ($8.71M) Mar 29, 2024
FY2022 Dec 31, 2021 ($13.14M) Mar 24, 2023
FY2021 Jun 30, 2021 ($15.52M) Oct 13, 2022
FY2021 Mar 31, 2021 ($17.15M) Oct 13, 2022
FY2021 Dec 31, 2020 ($18.55M) Oct 13, 2022
FY2020 Sep 30, 2020 ($24.37M) Oct 13, 2022
FY2020 Jun 30, 2020 ($25.75M) Oct 13, 2022

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2020 Dec 31, 2020 $6.34M Mar 26, 2021
FY2020 Dec 31, 2019 $265.0K Mar 26, 2021
FY2020 Dec 31, 2018 $259.0K Mar 26, 2021
FY2019 Dec 31, 2017 $1.26M Mar 30, 2020
FY2018 Dec 31, 2016 $1.29M Mar 22, 2019
FY2017 Dec 31, 2015 $1.53M Apr 17, 2018
FY2016 Dec 31, 2014 $5.06M Apr 17, 2017
FY2015 Dec 31, 2013 $3.31M Apr 14, 2016
FY2014 Dec 31, 2012 $936.9K Mar 31, 2015
FY2013 Dec 31, 2011 $354.9K Mar 28, 2014

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $13.13M Mar 27, 2025
FY2023 Dec 31, 2023 $20.13M Mar 29, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2024 Dec 31, 2023 0 Mar 27, 2025
FY2023 Dec 31, 2022 0 Mar 29, 2024
FY2022 Dec 31, 2021 1 Mar 24, 2023
FY2021 Jun 30, 2021 0 Oct 13, 2022
FY2021 Mar 31, 2021 0 Oct 13, 2022
FY2021 Dec 31, 2020 2 Oct 13, 2022
FY2020 Sep 30, 2020 1 Oct 13, 2022
FY2020 Jun 30, 2020 0 Oct 13, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Mar 31, 2026
FY2025 Dec 31, 2024 0 Mar 31, 2026
FY2024 Dec 31, 2023 0 Mar 27, 2025
FY2023 Dec 31, 2022 0 Mar 29, 2024
FY2022 Dec 31, 2021 1 Mar 24, 2023
FY2021 Jun 30, 2021 0 Oct 13, 2022
FY2021 Mar 31, 2021 0 Oct 13, 2022
FY2021 Dec 31, 2020 1 Oct 13, 2022
FY2020 Sep 30, 2020 1 Oct 13, 2022
FY2020 Jun 30, 2020 0 Oct 13, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 9.39M Mar 31, 2026
FY2025 Dec 31, 2024 9.21M Mar 31, 2026
FY2024 Dec 31, 2023 9.20M Mar 27, 2025
FY2023 Dec 31, 2022 4.51M Mar 29, 2024
FY2022 Dec 31, 2021 4.55M Mar 24, 2023
FY2021 Jun 30, 2021 4.44M Oct 13, 2022
FY2021 Mar 31, 2021 4.36M Oct 13, 2022
FY2021 Dec 31, 2020 4.24M Oct 13, 2022
FY2020 Sep 30, 2020 1.06M Oct 13, 2022
FY2020 Jun 30, 2020 1.06M Oct 13, 2022